The Patent Finder

NLS Pharmaceutics AG

Also on record
Records under this name other than the patents NLS Pharmaceutics AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Showing 1 to 3 of 3 · Back to NLS Pharmaceutics AG

PatentTitleStatus Expires Confidence
US 9,637,447Lauflumide and the Enantiomers Thereof, Method for Preparing Same and Therapeutic Uses Thereof
Lapsed on the fee record
Ended May 2, 2025 · High confidence
Lapsed on the fee recordEnded May 2, 2025High confidence
US 10,532,100Use of iron for treating attention deficit hyperactivity disorder in children
Lapsed on the fee record
Ended Jan 14, 2024 · High confidence
Lapsed on the fee recordEnded Jan 14, 2024High confidence
US 10,456,387Phacetoperane for treating of attention deficit hyperactivity disorder
Lapsed on the fee record
Ended Oct 29, 2023 · From the USPTO record
Lapsed on the fee recordEnded Oct 29, 2023From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited